Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ Lee, H. Cho, J. Y. Vietri, J. Dawson, E. Chaiyakunapruk, N.

The incremental net monetary benefit of higher-valent pneumococcal conjugate vaccines for adults: a systematic review and meta-analysis of economic evaluations

  • Adults
  • Older adults
  • Pneumococcal disease
  • Economic aspects
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Palotino-Ferreira, B. M. Rocha, S. V. Nunes-Silva, A. Souza-Gomes, A. F. Rodrigues, F. Coelho, P. Bachi, A. L. L. de Oliveira, R. A. de Barros, M. P. Furtado, G. E.

The influence of structured physical activity on vaccination response from adults to older individuals: a systematic review on the Immunoinflammatory crosstalk of COVID-19

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ de Almeida Santos, G. de Albuquerque Luna, E. J.

The influence of the COVID-19 pandemic on measles vaccination coverage

  • Newborn
  • Children
  • Adolescents
  • Measles
  • Coverage
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Wu, W. Liu, J. Guo, S. Zhao, H. Yang, X.

The protective efficacy of inactivated vaccine against hemorrhagic fever with renal syndrome A meta-analysis

  • All age groups
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Robitaille, J. Esser, K. King, C. Leask, J. Wiley, K. Vigod, S. Rodin, G. Bolotin, S. Shapiro, G. K.

The Relationship Between Postpartum Depression and Timely Child Vaccination: A Systematic Review

  • Newborn
  • Children
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Ali Sheikhi, R. Heidari, M. Doosti, P.

The role of religious leaders in the acceptance of COVID-19 vaccinations: a systematic review

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Shuai, T. Dong, M. Wu, P. Zhang, L. Feng, Z. Li, W. Liu, J.

The safety and efficacy of non-typeable Haemophilus influenzae and Moraxella catarrhalis vaccine in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials

  • All age groups
  • Haemophilus influenzae type B
  • Moraxella catarrhalis
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Moderate
2025 ∙ Valdecantos, R. L. Sorrentino, M. Mercogliano, M. Giordano, V. Trama, U. Triassi, M. Palladino, R.

The structural and organizational aspects of human papillomavirus vaccine affecting immunization coverage in Europe: a systematic review

  • Europe
  • Adolescents
  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Zhang, X. Zhao, T. Xie, T. Zhang, S. Xu, Q. Cheng, Y. Wei, H. He, A. Liu, B. Lu, Q. B. Jiang, Y. Cui, F.

Tracking the progress of maternal pertussis vaccination coverage among upper-middle- and high-income countries and territories - a systematic review and modeling study

  • Pregnant women
  • Pertussis
  • Coverage
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Jacobsen, I. M. Carlander, A. L. F. Aakilde, M. von Buchwald, C.

Trends in the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis following implementation of national HPV vaccination initiatives: a systematic review

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Critically low
Loading...